亨迪药业
(301211)
| 流通市值：44.31亿 | | | 总市值：44.31亿 |
| 流通股本：4.18亿 | | | 总股本：4.18亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 385,508,102.2 | 417,576,956.92 | 425,282,964.5 | 447,658,499.51 |
| 交易性金融资产 | 1,129,739,596.8 | 1,122,170,041.24 | 1,114,682,763.47 | 1,107,277,763.47 |
| 应收票据及应收账款 | 61,703,738.68 | 66,037,394.52 | 84,828,815.53 | 78,618,968.68 |
| 其中：应收票据 | 5,211,908.08 | 9,123,094.35 | 12,750,342.42 | 15,146,626.5 |
| 应收账款 | 56,491,830.6 | 56,914,300.17 | 72,078,473.11 | 63,472,342.18 |
| 应收款项融资 | 11,892,987.44 | 10,107,198.95 | 14,711,254.6 | 12,850,668.66 |
| 预付款项 | 10,267,488.6 | 4,828,309.6 | 6,398,573.81 | 4,562,437.01 |
| 其他应收款合计 | 16,801,623.9 | 6,018,463.55 | 4,877,105.74 | 4,151,904.4 |
| 存货 | 141,069,130.15 | 139,339,539.02 | 125,837,058.47 | 122,677,371.65 |
| 其他流动资产 | 20,215,479.33 | 18,983,976.26 | 15,589,640.03 | 13,806,017.15 |
| 流动资产合计 | 1,777,198,147.1 | 1,785,061,880.06 | 1,792,208,176.15 | 1,791,603,630.53 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 10,382,661.59 | 10,382,661.59 | 10,382,661.59 | 10,382,661.59 |
| 固定资产 | 494,161,313.26 | 503,947,852.21 | 512,241,522.02 | 515,746,923.96 |
| 在建工程 | 36,148,893.8 | 19,059,062.12 | 10,435,160.84 | 8,202,085.85 |
| 使用权资产 | 1,214,708.64 | 1,457,650.38 | 1,700,592.09 | 1,943,533.8 |
| 无形资产 | 66,772,850.6 | 67,319,023.74 | 66,297,188.35 | 66,825,447.76 |
| 开发支出 | 2,582,260 | 1,923,600 | 3,628,776.93 | 3,613,600 |
| 长期待摊费用 | 540,655.09 | 611,175.34 | 681,695.59 | 761,848.87 |
| 递延所得税资产 | 2,363,541.08 | 2,363,541.08 | 2,363,541.08 | 2,363,541.08 |
| 其他非流动资产 | 179,994.9 | 179,994.9 | 179,994.9 | 433,994.9 |
| 非流动资产合计 | 614,346,878.96 | 607,244,561.36 | 607,911,133.39 | 610,273,637.81 |
| 资产总计 | 2,391,545,026.06 | 2,392,306,441.42 | 2,400,119,309.54 | 2,401,877,268.34 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 48,630,641.79 | 59,181,181.89 | 59,403,054.7 | 72,271,797.48 |
| 应付账款 | 48,630,641.79 | 59,181,181.89 | 59,403,054.7 | 72,271,797.48 |
| 合同负债 | 18,340,726 | 14,235,787.81 | 15,954,009.07 | 9,149,894.59 |
| 应付职工薪酬 | 12,761,873.01 | 11,668,449.27 | 10,392,301.61 | 13,433,333.02 |
| 应交税费 | 3,523,829.55 | 4,158,032.09 | 4,327,658.44 | 4,664,682.93 |
| 其他应付款合计 | 1,948,677.63 | 2,430,238.22 | 2,858,215.72 | 1,952,935.28 |
| 一年内到期的非流动负债 | 1,126,554.93 | 1,126,554.93 | 1,126,554.93 | 1,126,554.93 |
| 其他流动负债 | 4,854,211.98 | 8,328,416.66 | 10,263,788.8 | 11,950,642.32 |
| 流动负债合计 | 91,186,514.89 | 101,128,660.87 | 104,325,583.27 | 114,549,840.55 |
| 非流动负债: | | | | |
| 租赁负债 | 410,736.48 | 796,339.22 | 1,222,386.94 | 2,007,821.9 |
| 递延收益 | 1,936,419.18 | 1,945,532.4 | 1,954,645.62 | 1,963,758.84 |
| 递延所得税负债 | 10,127,764.71 | 10,127,764.71 | 10,127,764.71 | 10,127,764.71 |
| 非流动负债合计 | 12,474,920.37 | 12,869,636.33 | 13,304,797.27 | 14,099,345.45 |
| 负债合计 | 103,661,435.26 | 113,998,297.2 | 117,630,380.54 | 128,649,186 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 417,600,000 | 417,600,000 | 417,600,000 | 417,600,000 |
| 资本公积 | 1,626,912,267.22 | 1,626,912,267.22 | 1,626,912,267.22 | 1,626,912,267.22 |
| 其他综合收益 | 325,262.35 | 325,262.35 | 325,262.35 | 325,262.35 |
| 专项储备 | 53,733.16 | - | 42,783.01 | - |
| 盈余公积 | 61,020,576.93 | 61,020,576.93 | 61,020,576.93 | 61,020,576.93 |
| 未分配利润 | 181,971,751.14 | 172,450,037.72 | 176,588,039.49 | 167,369,975.84 |
| 归属于母公司股东权益合计 | 2,287,883,590.8 | 2,278,308,144.22 | 2,282,488,929 | 2,273,228,082.34 |
| 股东权益合计 | 2,287,883,590.8 | 2,278,308,144.22 | 2,282,488,929 | 2,273,228,082.34 |
| 负债和股东权益合计 | 2,391,545,026.06 | 2,392,306,441.42 | 2,400,119,309.54 | 2,401,877,268.34 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-23 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |